Immunome Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMNM is expected to report earnings to fall 17.14% to -53 cents per share on March 19
Q4'25
Est.
$-0.54
Q3'25
Missed
by $0.08
Q2'25
Beat
by $0.12
Q1'25
Beat
by $0.14
Q4'24
Missed
by $0.45
The last earnings report on November 07 showed earnings per share of -64 cents, missing the estimate of -56 cents. With 448.44K shares outstanding, the current market capitalization sits at 1.60B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMNM showed earnings on November 07, 2025. You can read more about the earnings report here.